Title: Message
Sending prayers for Lucy.
Kerry
-----Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of [EMAIL PROTECTED]
Sent: Tuesday, September 05, 2006 10:10 AM
To: [email protected]
Subject: Lucy again

If you have prayers to spare in this terrible week with so many sick cats, please say a little one for Lucy.  This time she relapsed at 7.5 mg/day of pred.  I am more worried that her ibd could be morphing into lymphoma, as that is a pretty high dose. But maybe I just tapered her too quickly. I am back up to 10 a day and will taper more slowly, but am worried my vet will not refill as he thinks that is too much pred and that she should get a scope if she needs that much. Though I don't see the point, since even if she has lymphoma they would put her on that much pred anyway, and if the pred stops working they use leukeran with both lymphoma and severe ibd, so what is the point of the 3 hours of driving and invasive probes.  But I will have to see, because if my local vet will not keep prescribing the pred when she needs it, I may have no choice.
Michelle
 
IRS CIRCULAR 230 NOTICE. Any advice expressed above as to tax matters was neither written nor intended by the sender or Mayer, Brown, Rowe & Maw LLP to be used and cannot be used by any taxpayer for the purpose of avoiding tax penalties that may be imposed under U.S. tax law. If any person uses or refers to any such tax advice in promoting, marketing or recommending a partnership or other entity, investment plan or arrangement to any taxpayer, then (i) the advice was written to support the promotion or marketing (by a person other than Mayer, Brown, Rowe & Maw LLP) of that transaction or matter, and (ii) such taxpayer should seek advice based on the taxpayers particular circumstances from an independent tax advisor
 
This email and any files transmitted with it are intended solely for the use of the individual or entity to whom they are addressed. If you have received this email in error please notify the system manager. If you are not the named addressee you should not disseminate, distribute or copy this e-mail.

Reply via email to